Awardee OrganizationUT SOUTHWESTERN MEDICAL CENTER
Description
Abstract Text
The studies proposed in this application are designed to examine G
protein-dependent mechanisms by which transport is regulated in the renal
proximal tubule (PT). NaCl and NaHCO3 transport is reciprocally regulated
by hormones like angiotensin II (AngII) and a agonists which increase it,
and by PTH which decreases it. Receptors for these hormones are coupled by
G proteins to enzymes or ion channels which produce their biologic effects.
The enzymes and ion channels regulated by G proteins (effectors) may
include adenylyl cyclase (AC), phospholipases A2 and C (PLA2 and PLC), and
K and Ca channels. Most hormones regulate some, but not all of these
effectors. How the specificity of the signalling pathway is determined, how
effectors are regulated, and by which G proteins is not known in detail.
Hormones such as AngII and PTH activate multiple effectors in the PT, but
it is not clear if one G protein activates one or multiple effectors. It is
also not clear if a single G protein couples to one or multiple receptors.
The studies proposed in this application will address these questions: 1)
In situ hybridization studies in sections of rat kidneys using
oligonucleotide probes to six G proteins (Gs, Gil-3, Go, and Gz) will
determine which G proteins are expressed in the PT. 2) Western blotting of
renal cortical basloateral (BLMV) and brush border membranes (BBMV) with G
protein-specific antisera will establish the distribution of G proteins on
the apical and basolateral membranes of the PT. 3) The effectors (AC, PLA2,
PLC, and K and Ca channels), regulated by the G proteins expressed in the
PT will be determined by expressing mutant, constitutively active G
proteins in PT-like continuous cell lines (OK, BSC-1, or immortalized
primary cultures), and measuring the activity of the potential effectors.
Purified, preactivated recombinant G proteins will be reconstituted into
BLMV and BBMV, and K and Ca channel activity measured. 4) G
protein-receptor coupling will be established in BLMV and BBMV using
biochemical assays that identify a G protein that is activated by a
receptor, or by expressing a mutant G protein with abnormal receptor
coupling in a continuous renal cell line. PTH, AngII, and a adrenergic
agonists will be studied. 5) The ability of these G protein-dependent
signalling systems to regulate transport will be established by measuring
Na/H antiporter, Na/3HCO3 cotransporter, and Na,KATPase activity in cells
expressing activated G proteins and membrane vesicles containing
preactivated, recombinant G proteins. These studies will provide a better
understanding of how PT NaCl and NaHCO3 transport is regulated, and how
specificity for G protein-dependent signalling is determined.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
G proteinadenosinetriphosphataseadenylate cyclaseadrenergic receptorangiotensin IIantiportapical membranebicarbonatesbiological signal transductioncalcium channelcell linegenetic manipulationhormone regulation /control mechanismin situ hybridizationmembrane transport proteinsoligonucleotidesparathyroid hormonesphospholipase A2phospholipase Cpotassium channelrenal cortexrenal tubular transportsodiumwestern blottings
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
DUNS Number
800771545
UEI
YZJ6DKPM4W63
Project Start Date
01-August-1989
Project End Date
31-July-1994
Budget Start Date
01-August-1992
Budget End Date
31-July-1993
Project Funding Information for 1992
Total Funding
$103,950
Direct Costs
$70,000
Indirect Costs
$33,950
Year
Funding IC
FY Total Cost by IC
1992
National Institute of Diabetes and Digestive and Kidney Diseases
$103,950
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R29DK041726-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R29DK041726-04
Patents
No Patents information available for 5R29DK041726-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R29DK041726-04
Clinical Studies
No Clinical Studies information available for 5R29DK041726-04
News and More
Related News Releases
No news release information available for 5R29DK041726-04
History
No Historical information available for 5R29DK041726-04
Similar Projects
No Similar Projects information available for 5R29DK041726-04